RCT: Ozanimod as induction and maintenance therapy for ulcerative colitis.
27 Oct, 2021 | 01:19h | UTC
Commentary on Twitter
Visual Abstract: Ozanimod Therapy for Ulcerative Colitis https://t.co/P3XpOvV49P pic.twitter.com/ubqgQX94uW
— NEJM (@NEJM) October 6, 2021